Ferrières Jean
CHU Rangueil, TSA 50032, fédération de cardiologie, 31059 Toulouse cedex 9, France.
Presse Med. 2017 Jul-Aug;46(7-8 Pt 1):688-696. doi: 10.1016/j.lpm.2017.03.008. Epub 2017 May 10.
Cardiovascular risk evaluation is a fundamental approach in cardiovascular prevention. Cardiovascular risk categories are associated with lipid-lowering drug intensity. LDL cholesterol is the main target of treatment. Statins are the first line lipid-lowering drugs. Lipid-lowering combination therapy is to be used in order to obtain the LDL cholesterol targets. Screening of familial hypercholesterolemia might be included in all prevention population strategy.
心血管风险评估是心血管疾病预防的基本方法。心血管风险类别与降脂药物强度相关。低密度脂蛋白胆固醇是主要治疗靶点。他汀类药物是一线降脂药物。为达到低密度脂蛋白胆固醇目标，可采用联合降脂治疗。在所有预防人群策略中都可纳入家族性高胆固醇血症的筛查。
